Julia G. Butchko
Corporate Officer/Principal bei IMMUNOVANT, INC.
Vermögen: 6 Mio $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Julia G. Butchko
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 29 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Julia G. Butchko
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal President Director of Finance/CFO | |
Immunovant Sciences Ltd.
 Immunovant Sciences Ltd. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Immunovant Sciences Ltd. develops restorative therapies for autoimmune diseases. The company is based in Hamilton, Bermuda. Immunovant Sciences was acquired by Health Sciences Acquisitions Corp. from Roivant Sciences Ltd. on December 19, 2019 for $863.06 million. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Chairman | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| MYOVANT SCIENCES LTD. | Biotechnology | Chairman Director/Board Member | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IMMUNOMEDICS, INC. | Biotechnology | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Aruvant Sciences, Inc. operates as a clinical-stage biopharmaceutical company. The firm develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning. It's lead candidate ARU-1801, is a modified fetal hemoglobin gene therapy for sickle cell disease and related hemoglobinopathies. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree Undergraduate Degree | |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | General Counsel Founder | |
| EARGO, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | Biotechnology | Director of Finance/CFO Director/Board Member | |
| The University of Chicago | College/University | Director/Board Member Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| The University of Nebraska-Lincoln | College/University | Doctorate Degree | |
| University of Iowa | College/University | Graduate Degree | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Long Island University | College/University | Undergraduate Degree | |
| ABBVIE INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Flexion, Inc.
 Flexion, Inc. Information Technology ServicesTechnology Services Flexion, Inc. is an American company that offers services to help businesses with digital transformation, innovative development, and modernization. The private company provides IT staffing and work to improve the efficiency, security, and user experience of their clients' systems. Flexion uses a rigorous agile practice to build flexible solutions that enable their clients' businesses to grow. | Information Technology Services | General Counsel | |
| New York University School of Medicine | College/University | Corporate Officer/Principal | |
| Stony Brook University School of Medicine | College/University | Doctorate Degree | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology AM-Pharma Holding BV operates as a financial holding company with interests in the bio-medical sector. The company was founded by Rudd Brands and is headquartered in Bunnik, Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member | |
KVP Capital Advisors LP
 KVP Capital Advisors LP Investment ManagersFinance KVP Capital Advisors LP provides investment advice. The private company is based in San Francisco, CA. | Investment Managers | Corporate Officer/Principal | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
| Marquette University | College/University | Undergraduate Degree | |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Medical Specialties | Director/Board Member | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Chairman | |
Respivant Sciences, Inc.
 Respivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Respivant Sciences, Inc. is a clinical-stage biopharmaceutical company that develops therapies for patients with respiratory diseases. The company is based in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | Investment Managers | Corporate Officer/Principal | |
| UNC School of Medicine | College/University | Doctorate Degree | |
Point32health Services, Inc.
 Point32health Services, Inc. Life/Health InsuranceFinance Tufts Associated Health Plans, Inc. provides healthcare plans. It offers health care coverage options to individuals and employer groups. The firm also offers choice tiered network option plan and Steward Community Choice, a community-based plan, developed in conjunction with Steward Health Care System. The company was founded by Morton A. Madoff in 1979 and is headquartered in Watertown, MA. | Life/Health Insurance | Director/Board Member | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Chairman | |
| Focus Biomedical Consulting LLC | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 43 |
| Vereinigtes Königreich | 4 |
| Niederlande | 3 |
| Bermuda | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 32 |
| Consumer Services | 11 |
| Finance | 4 |
| Commercial Services | 3 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 105 |
| Corporate Officer/Principal | 46 |
| Independent Dir/Board Member | 27 |
| Undergraduate Degree | 21 |
| Chief Executive Officer | 19 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Myrtle Potter | 42 |
| Frank Torti | 35 |
| Atul Pande | 20 |
| George Migausky | 18 |
| Andrew Fromkin | 16 |
| Douglas Hughes | 15 |
| Rita Jain | 14 |
| W. Middlekauff | 14 |
| Eric Venker | 12 |
| Sandeep Kulkarni | 11 |
| Peter Salzmann | 10 |
| Pamela Connealy | 10 |
| Mark Levine | 8 |
| John Strumbos | 7 |
| William L. Macias | 7 |
- Börse
- Insiders
- Julia G. Butchko
- Unternehmensverbindungen
